• Explore /
  • Poster
  • / Survival outcomes in patients receiving immune checkpoint inhibitor (ICI) for metastatic small cell urothelial cancer (SCUC).

Survival outcomes in patients receiving immune checkpoint inhibitor (ICI) for metastatic small cell urothelial cancer (SCUC).

Abstract Poster

Authors

Omar Alhalabi

Omar Alhalabi

Beaumont Health, Royal Oak, TX

Omar Alhalabi , Nathaniel Wilson , Neema Navai , Matthew T Campbell , Amishi Yogesh Shah , Jianjun Gao , Paul G. Corn , Ana Aparicio , Bogdan Czerniak , Charles Guo , Christopher Logothetis , Nizar M. Tannir , Seungtaek Choi , Arlene O. Siefker-Radtke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4543)

DOI

10.1200/JCO.2021.39.15_suppl.4543

Abstract #

4543

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Olisaemeka Ogbue

First Author: Majd Issa

First Author: Rafael Morales-Barrera

First Author: Rohit K. Jain